Table 3.
Crude and adjusted odds ratio by hierarchical polytomous regression analysis of the association of characteristics of TB patients according to their M. tuberculosis isolates’ IS6110 RFLP cluster patterns (unique patterns for reference)
Crude OR | Adjustment OR | |||||
---|---|---|---|---|---|---|
Cluster Size | Cluster Size | |||||
2–5 | 6–9 | ≥ 10 | 2–5 | 6–9 | ≥ 10 | |
OR (CI) | OR (CI) | OR (CI) | OR (CI) | OR (CI) | OR (CI) | |
Level 1 | ||||||
Spoligotyping | ||||||
Non LAM | Ref | Ref | Ref | Ref | Ref | Ref |
LAM | 1.08 (1.01–1.15) | 1.18 (1.09–1.27) | 1.22 (1.14–1.31) | 1.08 (1.01–1.15) | 1.17 (1.08–1.26) | 1.22 (1.14–1.31) |
RDRio Genotype | ||||||
Non-RDRio | Ref | Ref | Ref | Ref | Ref | Ref |
RDRio | 0.91 (0.81–1.03) | 1.26 (1.15–1.38) | 1.06 (0.94–1.19) | 0.91 (0.80–1.03) | 1.25 (1.14–1.37) | 1.05 (0.93–1.18) |
Level 2 | ||||||
Metropolitan Area | ||||||
Vitoria | Ref | Ref | Ref | Ref | Ref | Ref |
Vila Velha | 0.92 (0.55–1.55) | 0.66 (0.28–1.53) | 0.73 (0.33–1.62) | 1.00 (0.59–1.69) | 0.74 (0.30–1.77) | 1.04 (0.46–2.36) |
Cariacica | 1.02 (0.64–1.62) | 0.70 (0.32–1.47) | 1.27 (0.69–2.33) | 1.12 (0.70–1.80) | 0.71 (0.32–1.58) | 1.81 (0.96–3.40) |
Serra | 0.93 (0.59–1.45) | 0.26 (0.09–0.75) | 0.83 (0.43–1.60) | 0.99 (0.63–1.55) | 0.29 (0.10–0.84) | 1.08 (0.55–2.11) |
Outros | 0.62 (0.28–1.36) | 0.71 (0.24–2.12) | 0.86 (0.32–2.34) | 0.66 (0.30–1.45) | 0.74 (0.24–2.28) | 1.04 (0.37–2.89) |
Level 3 | ||||||
Gender | ||||||
Female | Ref | Ref | Ref | Ref | Ref | Ref |
Male | 1.01 (0.73–1.40) | 1.16 (0.70–1.93) | 1.20 (0.75–1.92) | 0.98 (0.70–1.39) | 1.19 (0.69–2.05) | 1.20 (0.72–2.00) |
Age (years old) | ||||||
< 20 years | Ref | Ref | Ref | Ref | Ref | Ref |
21–30 years | 0.48 (0.28–0.83) | 0.42 (0.21–0.86) | 0.96 (0.42–2.19) | 0.49 (0.28–0.85) | 0.45 (0.21–0.97) | 1.13 (0.47–2.69) |
31–40 years | 0.44 (0.25–0.77) | 0.43 (0.21–0.88) | 0.95 (0.41–2.19) | 0.43 (0.24–0.77) | 0.41 (0.19–0.90) | 1.01 (0.42–2.43) |
41–50 years | 0.62 (0.36–1.09) | 0.31 (0.14–0.69) | 0.79 (0.33–1.90) | 0.61 (0.34–1.08) | 0.30 (0.12–0.70) | 0.93 (0.37–2.34) |
> 50 years | 0.51 (0.28–0.93) | 0.19 (0.07–0.50) | 0.72 (0.28–1.81) | 0.49 (0.26–0.91) | 0.18 (0.06–0.49) | 0.89 (0.33–2.37) |
Race | ||||||
White | Ref | Ref | Ref | Ref | Ref | Ref |
Black | 0.97 (0.56–1.69) | 1.27 (0.59–2.71) | 2.59 (1.21–5.54) | 0.82 (0.46–1.46) | 0.79 (0.351.81) | 2.02 (0.90–4.51) |
Others | 0.96 (0.63–1.46) | 0.90 (0.49–1.68) | 1.68 (0.87–3.26) | 0.89 (0.58–1.38) | 0.76 (0.39–1.49) | 1.53 (0.77–3.05) |
School level, years | ||||||
≤ 4 years | Ref | Ref | Ref | Ref | Ref | Ref |
4 to 8 years | 0.97 (0.58–1.62) | 1.09 (0.50–2.37) | 1.54 (0.67–3.53) | 0.89 (0.52–1.51) | 1.01 (0.42–2.41) | 1.49 (0.62–3.57) |
≥ 8 years | 0.82 (0.42–1.58) | 1.02 (0.38–2.73) | 1.28 (0.46–3.58) | 0.63 (0.31–1.27) | 0.70 (0.24–2.12) | 1.23 (0.41–3.70) |
Level 4 | ||||||
X-ray | ||||||
Negative | Ref | Ref | Ref | Ref | Ref | Ref |
Suspicious of TB | 0.60 (0.30–1.17) | 1.24 (0.35–4.29) | 0.71 (0.27–1.84) | 0.34 (0.14–0.79) | 0.35 (0.08–1.56) | 0.27 (0.08–0.92) |
Sputum smear results | ||||||
Negative | Ref | Ref | Ref | Ref | Ref | Ref |
Positive | 0.88 (0.60–1.31) | 2.68 (1.13–6.34) | 1.69 (0.87–3.30) | 0.69 (0.41–1.17) | 2.05 (0.68–6.16) | 1.24 (0.53–2.90) |
TB presentation | ||||||
PTB | Ref | Ref | Ref | Ref | Ref | Ref |
EPTB | 0.65 (0.40–1.05) | 0.41 (0.17–0.99) | 0.46 (0.21–1.00) | 0.44 (0.23–0.83) | 0.41 (0.13–1.21) | 0.37 (0.13–1.03) |
PTB + EPTB | 1.08 (0.63–1.86) | 0.26 (0.06–1.09) | 0.65 (0.27–1.60) | 0.94 (0.49–1.78) | 0.29 (0.06–1.34) | 0.68 (0.23–1.98) |
OR odds ratio, CI confidence interval, SD standard deviation, TB tuberculosis, PTB pulmonary TB, EPTB extrapulmonary TB. *Hierarchical levels: Level 1 = Spoligotyping + RDRio genotype; Level 2 = Spoligotyping + RDRio genotype + Metropolitan Area; Level 3 = Spoligotyping + RDRio genotype + Metropolitan Area + Gender +Age + Race + Schooling; Level 4 = Spoligotyping + RDRio genotype + Metropolitan Area + Gender +Age + Race + Schooling + X-Ray + Sputum smear results + TB presentation